This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2011-2023.
Company Filing History:
Years Active: 2011-2023
Title: Lovelace Holman: Innovator in Pharmaceutical Compositions
Introduction
Lovelace Holman is a distinguished inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on developing stable pharmaceutical compositions that have the potential to improve patient outcomes.
Latest Patents
Among his latest innovations, Lovelace has developed stable pharmaceutical compositions comprising a pyrimidine-sulfamide. This invention relates to stable pharmaceutical compositions that include the compound of a specific formula, as well as pharmaceutically acceptable salts, solvates, hydrates, or morphological forms thereof. His research in this area aims to enhance the efficacy and stability of pharmaceutical products.
Career Highlights
Lovelace Holman is currently associated with Actelion Pharmaceuticals Ltd., where he continues to push the boundaries of pharmaceutical research. His expertise and innovative approach have positioned him as a key player in the industry, contributing to advancements that benefit both healthcare providers and patients.
Collaborations
Throughout his career, Lovelace has collaborated with notable colleagues, including Olivier Lambert and Bruce Hamilton Lithgow. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical sector.
Conclusion
Lovelace Holman's contributions to pharmaceutical compositions exemplify the impact of innovation in healthcare. His dedication to research and development continues to pave the way for advancements that can significantly improve therapeutic options for patients.